These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 489968)

  • 41. EGF induces cell cycle arrest of A431 human epidermoid carcinoma cells.
    MacLeod CL; Luk A; Castagnola J; Cronin M; Mendelsohn J
    J Cell Physiol; 1986 Apr; 127(1):175-82. PubMed ID: 3007537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells.
    Yutoku M; Grossberg AL; Pressman D
    J Immunol; 1975 Jul; 115(1):69-74. PubMed ID: 1097506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic modulation as a mechanism for tumor escape from immune destruction: identification of modulation-positive and modulation-negative mouse lymphomas with xenoantisera to murine leukemia virus gp70.
    Stackpole CW; Cremona P; Leonard C; Stremmel P
    J Immunol; 1980 Oct; 125(4):1715-23. PubMed ID: 6251136
    [No Abstract]   [Full Text] [Related]  

  • 44. Tumor rejection mediated by an amphotropic murine leukemia virus.
    Zbar B; Nagai A; Terata N; Hovis J
    Cancer Res; 1983 Jan; 43(1):46-53. PubMed ID: 6182993
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations.
    Konda S; Smith RT
    Cancer Res; 1973 Aug; 33(8):1878-84. PubMed ID: 4541721
    [No Abstract]   [Full Text] [Related]  

  • 46. Isolation and partial characterization of a 72,000-dalton glycoprotein (Tgp72) on human thymus and T cells: possible relationship to mouse Ly-1 antigens.
    Ishii Y; Fujimoto J; Koshiba H; Kikuchi K
    J Immunol; 1981 Jun; 126(6):2171-6. PubMed ID: 6971888
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
    Wiepz GJ; Houtman JC; Cha D; Bertics PJ
    J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Resistance to murine leukemia in mice receiving simultaneous injections of syngeneic hybrid and parental neoplastic cells.
    Liang W; Cohen EP
    J Immunol; 1977 Mar; 118(3):903-8. PubMed ID: 845440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. PPARgamma1 synthesis and adipogenesis in C3H10T1/2 cells depends on S-phase progression, but does not require mitotic clonal expansion.
    Cho YC; Jefcoate CR
    J Cell Biochem; 2004 Feb; 91(2):336-53. PubMed ID: 14743393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virus-specific T cell response prevents lymphoma development in mice infected by intrathymic inoculation of Moloney leukaemia virus (M-MuLV).
    Zanovello P; Collavo D; Ronchese F; De Rossi A; Biasi G; Chieco-Bianchi L
    Immunology; 1984 Jan; 51(1):9-16. PubMed ID: 6228521
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Radiation-induced murine leukemia ERLD in cell culture.
    Albrecht AM; Biedler JL; Hutchison DJ; Spengler BA; Stockert E
    Cancer Res; 1976 Oct; 36(10):3784-8. PubMed ID: 1066184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The neoantigens of cancer cells and their significance].
    Mathé G; Amiel JL; Doré JF
    Rev Fr Etud Clin Biol; 1968 Dec; 13(10):937-40. PubMed ID: 4308925
    [No Abstract]   [Full Text] [Related]  

  • 53. Ultrastructural and serological studies on the resistance of activated B cells to the cytotoxic effects of anti-immunoglobulin serum. Patch and cap formation of surface immunoglobulin on mitotic B lymphocytes.
    Kerbel RS; Birbeck MS; Robertson D; Cartwright P
    Clin Exp Immunol; 1975 Apr; 20(1):161-77. PubMed ID: 1106920
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and processing of molecules bearing thymus leukemia antigen.
    Rothenberg E; Boyse EA
    J Exp Med; 1979 Oct; 150(4):777-91. PubMed ID: 315985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antigenic modulation and down regulation-their similarities suggest they may have a common origin.
    Cohen EP
    Cancer Biochem Biophys; 1980; 4(4):237-43. PubMed ID: 6256059
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quantitative isolation of mouse thymus leukemia antigen, TL.
    Stanton TH; Bennett JC; Wolcott M
    Tissue Antigens; 1976 Mar; 7(3):158-64. PubMed ID: 936201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes: retention of modulating antibody on the cell surface.
    Jacobson JB; Galuska S; Stackpole CW
    J Natl Cancer Inst; 1978 Sep; 61(3):819-25. PubMed ID: 80455
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Some biochemical properties of thymus leukemia antigens solubilized from cell membranes by papain digestion.
    Muramatsu T; Nathenson SG; Boyse EA; Old LJ
    J Exp Med; 1973 May; 137(5):1256-62. PubMed ID: 4540799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Purification of murine thymus leukemia antigen (TL). A quantitative assessment of limited proteolysis.
    Wolcott M; Stanton TH; Williams JL; Bennett JC
    Biochemistry; 1975 Nov; 14(22):4792-6. PubMed ID: 1182118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.